Myositis is generally more severe in anti-MJ/NXP2, whereas anti-MDA5 is associated with a severe interferon-1-mediated interstitial lung disease, potentially rapidly progressive with a poor prognosis [34]. Here, IFIH1 is linked to myositis disease.